Elisabeth Pfrogner

433 total citations
18 papers, 342 citations indexed

About

Elisabeth Pfrogner is a scholar working on Physiology, Immunology and Allergy and Dermatology. According to data from OpenAlex, Elisabeth Pfrogner has authored 18 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Immunology and Allergy and 5 papers in Dermatology. Recurrent topics in Elisabeth Pfrogner's work include Asthma and respiratory diseases (14 papers), Allergic Rhinitis and Sensitization (12 papers) and Contact Dermatitis and Allergies (4 papers). Elisabeth Pfrogner is often cited by papers focused on Asthma and respiratory diseases (14 papers), Allergic Rhinitis and Sensitization (12 papers) and Contact Dermatitis and Allergies (4 papers). Elisabeth Pfrogner collaborates with scholars based in Germany and Austria. Elisabeth Pfrogner's co-authors include Matthias Krämer, Gerd Rasp, Moritz Gröger, Christine A. Klemens, Sven Becker, Richard de la Chaux, A. Dreher, Martin Canis, John Martin Hempel and Sebastian Wendt and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The Laryngoscope and Clinical & Experimental Allergy.

In The Last Decade

Elisabeth Pfrogner

18 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Pfrogner Germany 10 251 244 93 53 44 18 342
Takahiro Ninomiya Japan 8 229 0.9× 215 0.9× 213 2.3× 24 0.5× 52 1.2× 19 355
Stefano Pizzimenti Italy 12 214 0.9× 138 0.6× 56 0.6× 49 0.9× 147 3.3× 28 397
Maria Skedinger Sweden 12 237 0.9× 167 0.7× 80 0.9× 36 0.7× 178 4.0× 17 436
Christine Segboer Netherlands 9 168 0.7× 203 0.8× 79 0.8× 24 0.5× 40 0.9× 14 275
W.J. Fokkens Netherlands 7 187 0.7× 205 0.8× 174 1.9× 36 0.7× 33 0.8× 18 334
Andrew Pedinoff United States 8 131 0.5× 104 0.4× 66 0.7× 13 0.2× 88 2.0× 14 231
Cristoforo Incorvaia Italy 13 287 1.1× 345 1.4× 18 0.2× 164 3.1× 62 1.4× 22 392
Marcy deTineo United States 16 496 2.0× 556 2.3× 127 1.4× 81 1.5× 120 2.7× 24 647
Berardino Mastropasqua Italy 9 476 1.9× 333 1.4× 18 0.2× 32 0.6× 327 7.4× 25 535
M C Sánchez Spain 8 240 1.0× 309 1.3× 44 0.5× 114 2.2× 44 1.0× 11 362

Countries citing papers authored by Elisabeth Pfrogner

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Pfrogner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Pfrogner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Pfrogner more than expected).

Fields of papers citing papers by Elisabeth Pfrogner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Pfrogner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Pfrogner. The network helps show where Elisabeth Pfrogner may publish in the future.

Co-authorship network of co-authors of Elisabeth Pfrogner

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Pfrogner. A scholar is included among the top collaborators of Elisabeth Pfrogner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Pfrogner. Elisabeth Pfrogner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Eder, Katharina, et al.. (2019). The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data. European Archives of Oto-Rhino-Laryngology. 277(2). 445–452. 7 indexed citations
2.
Gröger, Moritz, et al.. (2013). Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases. European Archives of Oto-Rhino-Laryngology. 270(10). 2667–2676. 31 indexed citations
3.
Gröger, Moritz, Christine A. Klemens, Sebastian Wendt, et al.. (2012). Mediators and Cytokines in Persistent Allergic Rhinitis and Nonallergic Rhinitis with Eosinophilia Syndrome. International Archives of Allergy and Immunology. 159(2). 171–178. 32 indexed citations
4.
Becker, Sven, Moritz Gröger, Martin Canis, Elisabeth Pfrogner, & Matthias Krämer. (2011). Tropomyosin sensitization in house dust mite allergic patients. European Archives of Oto-Rhino-Laryngology. 269(4). 1291–1296. 22 indexed citations
5.
Klemens, Christine A., et al.. (2007). Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy and Asthma Proceedings. 28(4). 434–441. 41 indexed citations
6.
Klemens, Christine A., et al.. (2007). Latex allergy, a special risk for patients of otorhinolaryngology and head and neck surgery?. American Journal of Otolaryngology. 28(2). 103–109. 1 indexed citations
7.
Pfrogner, Elisabeth, et al.. (2006). Klinik und Mediatorfreisetzung in der allergischen Früh- und Spätphasenreaktion. Laryngo-Rhino-Otologie. 85(2). 113–123. 2 indexed citations
8.
Krämer, Matthias, et al.. (2006). Factors contributing to nasal allergic late phase eosinophilia. American Journal of Otolaryngology. 27(3). 190–199. 31 indexed citations
9.
Rasp, Gerd, et al.. (2006). An approach of immunoneurological aspects in nasal allergic late phase.. PubMed. 26(5). 382–90. 2 indexed citations
10.
Krämer, Matthias, et al.. (2005). Humorale Mukosa-Immunantwort bei der Rhinitis allergica. Laryngo-Rhino-Otologie. 84(7). 503–510. 1 indexed citations
11.
Klemens, Christine A., et al.. (2005). Nasal cytokine pattern in allergic and viral rhinitis. Journal of Allergy and Clinical Immunology. 115(2). S275–S275. 1 indexed citations
12.
Krämer, Matthias, et al.. (2004). In vitro diagnosis of chronic nasal inflammation. Clinical & Experimental Allergy. 34(7). 1086–1092. 48 indexed citations
13.
Krämer, Matthias, et al.. (2004). In vitro diagnosis of chronic nasal inflammation. Journal of Allergy and Clinical Immunology. 113(2). S30–S30. 5 indexed citations
14.
Krämer, Matthias, et al.. (2001). Nasal IL-16 and MIP-1 α in Late-Phase Allergic Response. Allergy and Asthma Proceedings. 22(3). 127–132. 12 indexed citations
15.
Krämer, Matthias, Richard de la Chaux, A. Dreher, Elisabeth Pfrogner, & Gerd Rasp. (2001). Allergic Rhinitis does not Constitute a Risk Factor for Obstructive Sleep Apnea Syndrome. Acta Oto-Laryngologica. 121(4). 494–499. 13 indexed citations
16.
Krämer, Matthias, Richard de la Chaux, A. Dreher, Elisabeth Pfrogner, & Gerd Rasp. (2001). Allergic Rhinitis does not Constitute a Risk Factor for Obstructive Sleep Apnea Syndrome. Acta Oto-Laryngologica. 121(4). 494–499. 38 indexed citations
18.
Rasp, Gerd, et al.. (1999). IL-5, IgE, ECP, and ICAM-1 in nasal secretions of patients suffering from chronic, non-allergic sinusitis, allergic rhinitis, and non-allergic nasal polyposis. 2. 247. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026